What FDA’s record states
| Field | What FDA’s record states | Source |
|---|---|---|
| Recipient | Premium Health Management Inc. dba Premium Health | FDA letter ↗ |
| Location | Santa Ana, CA | FDA letter ↗ |
| Letter date | Feb 20, 2026 | FDA letter ↗ |
| Posted by FDA | Mar 5, 2026 | FDA index ↗ |
| Issuing office | Center for Drug Evaluation and Research (CDER) | FDA letter ↗ |
| Subject | False & Misleading Claims/Misbranded (Telehealth) | FDA letter ↗ |
| MARCS-CMS number | 721474 | FDA letter ↗ |
| GLP-1 drugs named | Semaglutide, Tirzepatide | FDA letter ↗ |
| Response letter | Not published by FDA | FDA letter ↗ |
| Closeout letter | Not published by FDA | FDA letter ↗ |
“Suite 224 Santa Ana , CA 92705 United States cs@premiumhealth.us Issuing Office: Center for Drug Evaluation and Research (CDER) United States WARNING LETTER February 20, 2026 Premium Health: This letter is to advise you that the United States Food and Drug Administration (FDA) reviewed your website content at the internet address https://premiumhealth.us, in December 2025, and has observed that your website offers compounded drug products, including semaglutide and tirzepatide drug products.”FDA warning letter to Premium Health Management Inc. dba Premium Health, Feb 20, 2026 · read the full letter on fda.gov ↗
What this is and is not.A warning letter is FDA’s statement of what it considers significant violations. It is an allegation, not a court finding, and the firm can respond. A closeout letter is posted when FDA confirms the violations were corrected.
Other GLP-1 letters FDA issued that week
24HrDoc, Inc. dba 24HrDocFeb 20, 2026Alan Health Technologies Inc. dba AlanFeb 20, 2026Aspen Aesthetics dba Fifty 410Feb 20, 2026Belle Health LLC dba BelleFeb 20, 2026Better Health Labs, Inc. dba MeasuredFeb 20, 2026Bliv Wellness LLC dba BlivFeb 20, 2026BluefitMDFeb 20, 2026Deluxe IV Aesthetics PLLC dba Deluxe IV and AestheticsFeb 20, 2026Dripgym Mobile Parent, LLC dba Amp HealthFeb 20, 2026FitRX, LLC dba FitRxFeb 20, 2026Genesis Health International Inc. dba GenesisFeb 20, 2026Good Girl LLC dba GoodGirlRXFeb 20, 2026
And 17 more in the full list.
Source
Every field above is copied from FDA’s page for this letter, read Oct 3, 2026. The letter on fda.gov ↗ · All 161 GLP-1 warning letters